The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | G | Genito urinary system and sex hormones | |
| 2 | G02 | Other gynecologicals | |
| 3 | G02C | Other gynecologicals | |
| 4 | G02CB | Prolactine inhibitors |
| Code | Title | |
|---|---|---|
| G02CB01 | Bromocriptine | |
| G02CB02 | Lisuride | |
| G02CB03 | Cabergoline | |
| G02CB04 | Quinagolide | |
| G02CB05 | Metergoline | |
| G02CB06 | Terguride |
| Active Ingredient | Description | |
|---|---|---|
| Bromocriptine |
Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications. |
|
| Cabergoline |
Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity. |
|
| Lisuride |
|
|
| Metergoline |
|
|
| Quinagolide |
Quinagolide is a selective dopamine D2-receptor agonist not belonging to the chemical classes of ergot or ergoline compounds. Owing to its dopaminergic action, the drug exerts a strong inhibitory effect on the secretion of the anterior pituitary hormone prolactin, but does not reduce normal levels of other pituitary hormones. |
|
| Terguride |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| BRAMESTON Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| DOSTINEX Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MEDOCRIPTINE Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| NORPROLAC Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PARLODEL Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PIRODAL Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
